Using Spectral CT Imaging During Embolization and Tumor Ablation for Liver and Kidney Cancer

What this Trial Is About

This research aims to assess a new spectral CT imaging technique using Canon Medicals 4D CT system during image-guided procedures for liver and kidney cancers. The study focuses on evaluating the feasibility, image quality, and usefulness of this imaging during interventional oncology treatments such as embolization and ablation. It also explores assessing tissue changes during tumor ablation using this novel imaging technology. Participants include patients undergoing hepatic angiography mapping before trans arterial radioembolization TARE for liver cancer and those receiving image-guided tumor ablation with microwave ablation MWA or cryoablation for liver or kidney tumors. The study evaluates spectral CT images obtained during these procedures to support tumor identification, dose prediction, and ablation monitoring. During the study, participants will undergo imaging with spectral CT during their respective procedures. Researchers will assess image quality, procedural usefulness, and safety. Measurements include CT image quality at baseline, number and timing of images taken, and assessment of tissue changes. The study starts from screening, with follow-up assessments integrated into the treatment process, and continues until completion of imaging evaluations.

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology